Work

Abstract 6368: Correlative preclinical studies to elucidate mechanisms of synergy of the combination of the RAF/MEK clamp avutometinib and the FAK inhibitor defactinib in low grade serous ovarian cancer

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-6368

Authors: Lisa Pickard, Konstantinos Mitsopolous, Theo Roumeliotis, Silvia Coma, Laura Hover, Alexis De Haven Brandon, Bora Gurel, Jiin Song, Priya S. Hibshman, A Cole Edwards, Jeffrey A. Klomp, Clint A. Stalnecker, Adrienne D. Cox, Jyoti Choudhary, Channing Der, Jonathan A. Pachter, Udai Banerji

Institutions: Institute of Cancer Research, University of North Carolina at Chapel Hill, Verastem (United States)

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409631528

Cites:

Cited by:

Related to: 10